000 01828cam a2200349 a 4500
003 EG-GiCUC
005 20250223031007.0
008 140609s2013 ua d f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.11.33.Ph.D.2013.Mo.E
100 0 _aMohamed Hassany Barbary
245 1 0 _aEffect of vitamin D supplementation on end treatment response to peginterferon alfa - 2b / ribavirin combination in chronic hepatitis C genotype 4 /
_cMohamed Hassany Barbary ; Supervised Gamal Eldin Esmat Mohamed , Maissa Elsaid Elraziky , Wahid Halim Doss
246 1 5 _aتأثير اضافة فيتامين د على النتيجة النهائية لعلاج فيروس "سى" السلالة الرابعة باستخدام عقارى الأنترفيرون و الريبافيرن
260 _aCairo :
_bMohamed Hassany Barbary ,
_c2013
300 _a172 P. :
_bcharts ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
520 _aHCV infection is the main cause of chronic liver diseases. The current standard treatment for chronic HCV is not satisfactory especially with the moderate response rates and currently known side effects for the treatment. Many coming reports showed the possible role of vitamin D supplementation in sugmenting the response to SOC therapy of HCV
530 _aIssued also as CD
653 4 _aHCV
653 4 _aPegylated interferon
653 4 _aVitamin D
700 0 _aGamal Eldin Esmat Mohamed ,
_eSupervisor
700 0 _aMaissa Elsaid Elraziky ,
_eSupervisor
700 0 _aWahid Halim Doss ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aSamia
_eCataloger
942 _2ddc
_cTH
999 _c46220
_d46220